Clinical differences between small and large pheochromocytomas and paragangliomas
BackgroundPheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors, most of which are characterized by the release of catecholamine, and range in diameters from less than 1 cm to 10 cm or more. However, knowledge of the differences in clinical features between small and large PPGLs is...
| Published in: | Frontiers in Endocrinology |
|---|---|
| Main Authors: | Lin Zhao, ZhiMao Li, Xu Meng, Hua Fan, ZengLei Zhang, ZhaoCai Zhang, YeCheng Liu, XianLiang Zhou, HuaDong Zhu |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1087506/full |
Similar Items
Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study
by: Lin Zhao, et al.
Published: (2022-06-01)
by: Lin Zhao, et al.
Published: (2022-06-01)
Update on Modern Management of Pheochromocytoma and Paraganglioma
by: Jacques W. M. Lenders, et al.
Published: (2017-06-01)
by: Jacques W. M. Lenders, et al.
Published: (2017-06-01)
Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
by: Lin Zhao, et al.
Published: (2023-12-01)
by: Lin Zhao, et al.
Published: (2023-12-01)
Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma
by: Sun Hwa Lee, et al.
Published: (2020-03-01)
by: Sun Hwa Lee, et al.
Published: (2020-03-01)
Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review
by: Xu Wang, et al.
Published: (2023-04-01)
by: Xu Wang, et al.
Published: (2023-04-01)
The Biochemical–Imaging Connection: Urinary Noradrenaline and Fluorodeoxyglucose-Positron Emission Tomography in Unresectable or Metastatic Pheochromocytomas and Paragangliomas
by: Junki Takenaka, et al.
Published: (2025-05-01)
by: Junki Takenaka, et al.
Published: (2025-05-01)
Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
by: Graeme Eisenhofer, et al.
Published: (2022-07-01)
by: Graeme Eisenhofer, et al.
Published: (2022-07-01)
Association of NSE level with clinical features in pheochromocytoma/paraganglioma
by: LI Tianyi, ZHANG Wenqian, CHEN Yinghan, ZHOU Yue, CUI Yunying, WANG Yu, TONG Anli
Published: (2024-04-01)
by: LI Tianyi, ZHANG Wenqian, CHEN Yinghan, ZHOU Yue, CUI Yunying, WANG Yu, TONG Anli
Published: (2024-04-01)
Pheochromocytomas and paragangliomas in North African population: a single-tertiary center experience
by: Imane Rami, et al.
Published: (2025-05-01)
by: Imane Rami, et al.
Published: (2025-05-01)
Tumour microenvironment in pheochromocytoma and paraganglioma
by: Serena Martinelli, et al.
Published: (2023-03-01)
by: Serena Martinelli, et al.
Published: (2023-03-01)
Pheochromocytomas/Paragangliomas and two cases
by: W. van Vuuren, et al.
Published: (2007-06-01)
by: W. van Vuuren, et al.
Published: (2007-06-01)
Prevention and management of hypertensive crises in children with pheochromocytoma and paraganglioma
by: Chiara Bima, et al.
Published: (2024-08-01)
by: Chiara Bima, et al.
Published: (2024-08-01)
Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment
by: Magdalena Januszewicz, et al.
Published: (2021-05-01)
by: Magdalena Januszewicz, et al.
Published: (2021-05-01)
Hypermetabolism and Substrate Utilization Rates in Pheochromocytoma and Functional Paraganglioma
by: Ondřej Petrák, et al.
Published: (2022-08-01)
by: Ondřej Petrák, et al.
Published: (2022-08-01)
Review of Pediatric Pheochromocytoma and Paraganglioma
by: Reshma Bholah, et al.
Published: (2017-07-01)
by: Reshma Bholah, et al.
Published: (2017-07-01)
Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
by: Eu Jeong Ku, et al.
Published: (2021-04-01)
by: Eu Jeong Ku, et al.
Published: (2021-04-01)
Immune microenvironment of pheochromocytomas and paragangliomas
by: ZHOU Yue, TONG Anli
Published: (2024-06-01)
by: ZHOU Yue, TONG Anli
Published: (2024-06-01)
The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management
by: José Viana Lima Junior, et al.
Published: (2023-06-01)
by: José Viana Lima Junior, et al.
Published: (2023-06-01)
Clinical diagnosis of pheochromocytoma and paraganglioma‐induced secondary hypertension through UPLC‐MS/MS analysis of plasma catecholamines and their metabolites
by: Weiyun Zhang, et al.
Published: (2024-04-01)
by: Weiyun Zhang, et al.
Published: (2024-04-01)
The Use of Metyrosine in the Treatment of Pheochromocytoma and Paraganglioma Patients: A Review of the Literature
by: Mansura Babayeva, et al.
Published: (2025-05-01)
by: Mansura Babayeva, et al.
Published: (2025-05-01)
Misdiagnosis and analysis of clinical characteristics in patients with giant cystic pheochromocytoma/paraganglioma
by: Yue Zhang, et al.
Published: (2024-12-01)
by: Yue Zhang, et al.
Published: (2024-12-01)
Hereditary pheochromocytoma-associated syndromes. Part 1
by: M Yu Yukina, et al.
Published: (2015-09-01)
by: M Yu Yukina, et al.
Published: (2015-09-01)
Characteristics of pediatric pheochromocytoma/paraganglioma
by: Vijaya Sarathi
Published: (2017-01-01)
by: Vijaya Sarathi
Published: (2017-01-01)
Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas
by: Anastasiya Snezhkina, et al.
Published: (2021-11-01)
by: Anastasiya Snezhkina, et al.
Published: (2021-11-01)
An uncommon cause of hypertension: Paraganglioma revisited
by: Babulreddy Hanmayyagari, et al.
Published: (2015-01-01)
by: Babulreddy Hanmayyagari, et al.
Published: (2015-01-01)
External Beam Radiation Therapy in Treatment of Malignant Pheochromocytoma and Paraganglioma
by: Jennifer eVogel, et al.
Published: (2014-06-01)
by: Jennifer eVogel, et al.
Published: (2014-06-01)
Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma
by: Yuko Matsuo, et al.
Published: (2023-10-01)
by: Yuko Matsuo, et al.
Published: (2023-10-01)
Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report
by: Masahiro Shibata, et al.
Published: (2017-12-01)
by: Masahiro Shibata, et al.
Published: (2017-12-01)
Hereditary and clinical insights into paraganglioma and pheochromocytoma
by: Caitlin B Mauer Hall, et al.
Published: (2024-11-01)
by: Caitlin B Mauer Hall, et al.
Published: (2024-11-01)
Cancer Stem Cells in Pheochromocytoma and Paraganglioma
by: Laura D. Scriba, et al.
Published: (2020-02-01)
by: Laura D. Scriba, et al.
Published: (2020-02-01)
Editorial: Predictive tools in pheochromocytoma and paraganglioma
by: Filippo Ceccato, et al.
Published: (2023-06-01)
by: Filippo Ceccato, et al.
Published: (2023-06-01)
Pheochromocytoma/paraganglioma in children and adolescents: causes, pathogenesis, clinics, diagnostics, treatment (part 1)
by: V. V. Smirnov, et al.
Published: (2021-06-01)
by: V. V. Smirnov, et al.
Published: (2021-06-01)
Pheochromocytoma/paraganglioma in children and adolescents: causes, pathogenesis, clinics, diagnostics, treatment (part 2)
by: V. V. Smirnov, et al.
Published: (2021-06-01)
by: V. V. Smirnov, et al.
Published: (2021-06-01)
Pheochromocytoma/paraganglioma-associated cardiomyopathy
by: Alicja Szatko, et al.
Published: (2023-07-01)
by: Alicja Szatko, et al.
Published: (2023-07-01)
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
by: Giuseppina De Filpo, et al.
Published: (2023-06-01)
by: Giuseppina De Filpo, et al.
Published: (2023-06-01)
Research in Robot-assisted Surgery for Pheochromocytoma and Paraganglioma
by: OU Minjie, et al.
Published: (2024-07-01)
by: OU Minjie, et al.
Published: (2024-07-01)
Whole transcriptome analysis of canine pheochromocytoma and paraganglioma
by: Marit F. van den Berg, et al.
Published: (2023-08-01)
by: Marit F. van den Berg, et al.
Published: (2023-08-01)
DNA methylation analysis in malignant pheochromocytoma and paraganglioma
by: Toshihiro Oishi, et al.
Published: (2017-03-01)
by: Toshihiro Oishi, et al.
Published: (2017-03-01)
Supportive Management of Patients with Advanced Pheochromocytomas and Paragangliomas Receiving PRRT
by: Erica S. Tsang, et al.
Published: (2021-07-01)
by: Erica S. Tsang, et al.
Published: (2021-07-01)
The Role of the Metabolome and Non-Coding RNA on Pheochromocytomas and Paragangliomas: An Update
by: Bruno Bouça, et al.
Published: (2022-02-01)
by: Bruno Bouça, et al.
Published: (2022-02-01)
Similar Items
-
Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study
by: Lin Zhao, et al.
Published: (2022-06-01) -
Update on Modern Management of Pheochromocytoma and Paraganglioma
by: Jacques W. M. Lenders, et al.
Published: (2017-06-01) -
Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
by: Lin Zhao, et al.
Published: (2023-12-01) -
Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma
by: Sun Hwa Lee, et al.
Published: (2020-03-01) -
Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review
by: Xu Wang, et al.
Published: (2023-04-01)
